Covered recipient · General Payments record
KAREN K BERRIS
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$2,300.13
- Reported across 126 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $456.05 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $167.61 | 13 |
| PFIZER INC. | $84.37 | 5 |
| Abbott Laboratories | $55.47 | 3 |
| Insulet Corporation | $53.21 | 2 |
| Amgen Inc. | $43.39 | 3 |
| Amphastar Pharmaceuticals, Inc. | $18.38 | 1 |
| Xeris Pharmaceuticals, Inc. | $17.08 | 1 |
| MannKind Corporation | $16.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.45 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125327438 | CMS |
| Abbott Laboratories | $19.39 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125327440 | CMS |
| Abbott Laboratories | $19.63 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125327442 | CMS |
| Amgen Inc. | $13.53 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111529304 | CMS |
| Amgen Inc. | $13.20 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111529306 | CMS |
| Amgen Inc. | $16.66 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111529308 | CMS |
| Amphastar Pharmaceuticals, Inc. | $18.38 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149957780 | CMS |
| Insulet Corporation | $29.38 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116804874 | CMS |
| Insulet Corporation | $23.83 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116811685 | CMS |
| Mannkind Corporation | $16.54 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145839637 | CMS |
| Novo Nordisk Inc | $1.69 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097254234 | CMS |
| Novo Nordisk Inc | $16.79 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097769934 | CMS |
| Novo Nordisk Inc | $9.66 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096893581 | CMS |
| Novo Nordisk Inc | $16.87 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096932243 | CMS |
| Novo Nordisk Inc | $19.18 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097029077 | CMS |
| Novo Nordisk Inc | $0.91 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097229465 | CMS |
| Novo Nordisk Inc | $14.95 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097561032 | CMS |
| Novo Nordisk Inc | $15.83 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097583316 | CMS |
| Novo Nordisk Inc | $17.34 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096757996 | CMS |
| Novo Nordisk Inc | $4.18 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096572358 | CMS |
| Novo Nordisk Inc | $22.55 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096940940 | CMS |
| Novo Nordisk Inc | $5.58 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096689338 | CMS |
| Novo Nordisk Inc | $22.08 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097179954 | CMS |
| PFIZER INC. | $13.55 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131015490 | CMS |
| PFIZER INC. | $15.22 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131058828 | CMS |
| PFIZER INC. | $17.24 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131489095 | CMS |
| PFIZER INC. | $19.71 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131837236 | CMS |
| PFIZER INC. | $18.65 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131210708 | CMS |
| Xeris Pharmaceuticals, Inc. | $17.08 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144600960 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.